NANOHMICS INC — Department of Health and Human Services SBIR Phase I: ODCDC

NANOHMICS INC — SBIR Phase I award from Department of Health and Human Services.

Amount
$150,000
Agency
Department of Health and Human Services · Centers for Disease Control and Prevention
Program / Phase
SBIR · Phase I
Topic
ODCDC
NAICS
Place of performance
TX
Period

Description

Nanohmics proposes to develop ultrasensitive and specific antibody based sandwich lateral flowLFtest strips for influenza A and B hemagglutinins and neuraminidasesas well as Group A StreptococcusSpyogenesfrom throat and nasal swabs or saliva samplesVery good LF test strips are already marketed for these highly important disease analytesBut to improve detectionNanohmics will incorporate fluorescent quantum dotsQdots or QDsfor ultrasenisitive detection limits and adapt the IC LF assays to smart phone based portable readersQdots will also be used to produce multiplexed LF test strips with multiple different colored fluorescent test lines at different locations on one LF strip using just one UV light sourceIn PhaseNanohmics will review the current commercially available smart phone enabled LF test strip reader devices and software applications for mobile diagnosticsIn PhaseNanohmics will develop its own smart phone controlled fluorescence LF test strip reader and associated software applications